• January 23, 2003Business integration between Kyorin Pharmaceutical Co.,Ltd.and the Medical & Pharmaceutical Business Group of Teijin Ltd.
• December 12, 2002Kyorin Pharmaceutical and Bayer Yakuhin reached a co-marketing agreement on Anti-allergic rhinitis , "Baynas"
• December 5, 2002Dainippon and Kyorin have formed an alliance for Aldose Reductase Inhibitor
• September 19, 2002Notice of Revision of Earnings Estimates
• September 9, 2002We will startmarketing Predonema Enema 20mg , a therapeutic drug for ulcerative colitis and regional enterocolitis
• August 1, 2002Establishment of Research and Development Facility of Healthcare, "Health Science Center"
• July 31, 2002Kyorin commences a new joint research project with Scottish Biomedical
• July 30, 2002Application of New Quinolone Antimicrobial Drug "Gatifloxacin Ophthalmic Solution" in the US
• June 11, 2002Launch of GATIFLO Tablet100mg a broad-spectrum oral antibacterial agent
• June 4, 2002Conclsion of Co-research Contact with ActivX BIosciences,Inc.
• March 19, 2002Kyorin Pharmaceutical announces a sales rights transfer agreement for anti-bacterial agent with GaldermaK.K
• March 11, 2002Kyorin Europe GmbH opens its doors for business
• December 20, 2001Revaluation of Cerebrovascular Uses for Bronchial Asthma and Cerebrovascular Agent KETAS Capsules
• November 27, 2001Basic Memorandum of Understanding to Co-develop the Anti-Fungal Agent PEKIRON Nail lacquer
• November 8, 2001Grunenthal Obtains German Approval For New Quinolone AntiBiotic [Gatifloxacin]
• September 10, 2001Notice Concerning Share Spilt (gratis issue)
• August 31, 2001Launch of [KIPRES Tablet], Leukotriene Receptor Antagonist/Bronchial Asthma Treatment Medicine in Japan
• May 22, 2001Mid-Term Business Plan - Kyorin MIC-05 Plan
• April 16, 2001Business start of US-based corporation, Kyorin USA, Inc

1 2 3